Journal of Vascular Medicine & Surgery

Rooney M

Publications

• Research Article
  Growth and Tolerability of Healthy Term Infants Fed a New Formula Supplemented with DHA from Schizochytrium sp Microalgae
  Author(s): Mehta P*, Shepard J, Rouse K, Sullivan T, McCarthy D, Yurko-Mauro K, Rooney M, Schallon D and Secic M Mehta P*, Shepard J, Rouse K, Sullivan T, McCarthy D, Yurko-Mauro K, Rooney M, Schallon D and Secic M
  
  Objective: To evaluate growth and tolerability of infants fed a formula supplemented with docosahexaenoic acid (DHA) from a new strain of Schizochytrium sp (DHASCO®-B) microalgae. Methods: Healthy term infants (n=159) with weights ≥2500 gram were randomized on or before 14th day of life (DOL) to receive either DHASCO®-B or reference formula (DHASCO®) obtained from Crypthecodinium cohnii until DOL 120. Both formulas also contained arachidonic acid (ARA). Assessments included weight, length, weight/length ratio, head circumference, red blood cell (RBC) DHA and other fatty acids, metabolic panel, safety, and tolerance. Results: The rate of mean daily weight gain (±SD) at DOL 120 was not significantly different between the formulas, 29.1 ± 5.92 grams/day versus 29.9 ± 7.40 grams/day for DHASCO&re.. View More»
  DOI: 10.4172/2329-6925.1000267

  Abstract PDF